NASDAQ : STOK
Stoke Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 26.29 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 1.70B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Stoke Therapeutics, Inc. (STOK) reported revenue of 28.21M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 28.21M | 184.42M | 36.55M | 8.78M | 12.40M | |
| Gross Profit | 28.21M | 184.42M | 36.55M | 8.78M | 12.40M | |
| Selling, General & Admin | 95.11M | 67.09M | 48.79M | 41.32M | 38.92M | 31.90M |
| Research & Development | 190.70M | 137.92M | 89.13M | 82.23M | 77.84M | 54.17M |
| Operating Expenses | 285.81M | 205.01M | 137.93M | 123.55M | 116.76M | 86.06M |
| Operating Income | -257.60M | -20.59M | -101.37M | -114.77M | -104.36M | -86.06M |
| Interest Expense | -9.00K | -9.00K | -26.00K | -49.00K | ||
| Interest & Investment Income | 14.19M | 13.77M | 12.66M | 9.96M | 3.12M | 120.00K |
| Other Non Operating Income (Expenses) | 223.00K | -51.00K | -247.00K | 166.00K | 167.00K | 140.00K |
| Pretax Income | -243.20M | -6.88M | -88.98M | -104.70M | -101.07M | -85.81M |
| Net Income | -243.20M | -6.88M | -88.98M | -104.70M | -101.07M | -85.81M |
| Net Income to Common | -243.20M | -6.88M | -88.98M | -104.70M | -101.07M | -85.81M |
| Shares Outstanding (Basic) | 64.89M | 59.22M | 54.01M | 43.99M | 38.90M | 36.74M |
| Shares Outstanding (Diluted) | 64.89M | 59.22M | 54.01M | 43.99M | 38.90M | 36.74M |
| EPS (Basic) | -3.75 | -0.12 | -1.65 | -2.38 | -2.60 | -2.34 |
| EPS (Diluted) | -3.75 | -0.12 | -1.65 | -2.38 | -2.60 | -2.34 |
| Free Cash Flow | 44.91M | -87.05M | -82.68M | -35.83M | -68.11M | |
| Free Cash Flow Per Share | 0.76 | -1.61 | -1.88 | -0.92 | -1.85 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -913.16% | -11.16% | -277.31% | -1,307.21% | -841.24% | |
| Profit Margin | -862.10% | -3.73% | -243.42% | -1,192.47% | -814.73% | |
| Free Cash Flow Margin | 24.36% | -238.15% | -941.72% | -288.82% | ||
| EBITDA | -255.82M | -18.82M | -99.19M | -112.30M | -102.81M | -85.09M |
| EBITDA Margin | -10.21% | -271.36% | ||||
| D&A For EBITDA | 1.78M | 1.77M | 2.18M | 2.47M | 1.55M | 974.00K |
| EBIT | -257.60M | -20.59M | -101.37M | -114.77M | -104.36M | -86.06M |
| EBIT Margin | -11.16% | -277.31% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 107.27M | 84.22M | 127.98M | 191.44M | 113.56M | 144.90M |
| Short-Term Investments | 211.92M | 200.45M | 88.92M | 9.95M | 116.04M | 74.92M |
| Cash & Short-Term Investments | 319.19M | 284.67M | 216.90M | 201.39M | 229.59M | 219.81M |
| Accounts Receivable | 8.54M | 5.94M | 1.67M | |||
| Other Receivables | 1.53M | 1.97M | 700.00K | 64.00K | 588.00K | 132.00K |
| Receivables | 10.08M | 7.91M | 2.37M | 64.00K | 588.00K | 132.00K |
| Prepaid Expenses | 17.60M | 8.74M | 11.12M | 11.32M | 10.93M | 6.94M |
| Restricted Cash | 494.00K | 75.00K | ||||
| Other Current Assets | 7.56M | 3.90M | 2.30M | 2.56M | 2.96M | 2.33M |
| Total Current Assets | 354.42M | 305.70M | 232.76M | 215.34M | 244.07M | 229.22M |
| Property, Plant & Equipment | 9.45M | 6.25M | 8.25M | 12.43M | 11.43M | 9.08M |
| Long-Term Investments | 39.60M | 106.26M | 29.82M | |||
| Other Long-Term Assets | 3.23M | 227.00K | 721.00K | 569.00K | 569.00K | 569.00K |
| Total Assets | 406.69M | 418.43M | 271.56M | 228.34M | 256.07M | 238.87M |
| Accounts Payable | 4.03M | 4.94M | 2.50M | 1.70M | 766.00K | 2.38M |
| Accrued Expenses | 38.58M | 36.97M | 15.49M | 10.90M | 12.88M | 12.71M |
| Current Portion of Leases | 3.01M | 2.32M | 2.06M | 2.36M | 1.51M | |
| Current Unearned Revenue | 6.36M | 11.90M | 18.99M | 15.31M | 14.88M | |
| Other Current Liabilities | 1.06M | 753.00K | 857.00K | 509.00K | 540.00K | |
| Total Current Liabilities | 48.98M | 57.88M | 40.06M | 30.82M | 31.39M | 17.14M |
| Long-Term Leases | 681.00K | 1.14M | 2.45M | 4.77M | 2.72M | 3.53M |
| Long-Term Unearned Revenue | 4.45M | 6.96M | 33.07M | 36.86M | ||
| Other Long-Term Liabilities | 26.00K | 111.00K | 251.00K | 417.00K | ||
| Total Liabilities | 54.10M | 65.98M | 42.53M | 68.78M | 71.22M | 21.09M |
| Common Stock | 6.00K | 5.00K | 5.00K | 5.00K | 4.00K | 4.00K |
| Additional Paid-In Capital | 1.04B | 849.62M | 720.00M | 561.43M | 483.17M | 414.02M |
| Retained Earnings | -682.98M | -497.71M | -490.83M | -401.85M | -297.15M | -196.08M |
| Comprehensive Income & Other | -1.05M | 543.00K | -151.00K | -24.00K | -1.18M | -168.00K |
| Total Common Equity | 352.59M | 352.46M | 229.02M | 159.56M | 184.85M | 217.78M |
| Shareholders' Equity | 352.59M | 352.46M | 229.02M | 159.56M | 184.85M | 217.78M |
| Total Liabilities & Equity | 406.69M | 418.43M | 271.56M | 228.34M | 256.07M | 238.87M |
| Total Debt | 681.00K | 4.15M | 4.77M | 6.83M | 5.08M | 5.04M |
| Net Cash (Debt) | 358.11M | 386.78M | 241.95M | 194.56M | 224.52M | 214.77M |
| Net Cash Per Share | 5.52 | 6.53 | 4.48 | 4.42 | 5.77 | 5.85 |
| Filing Date Shares Outstanding | 64.81M | 59.15M | 54.08M | 46.30M | 44.15M | 37.36M |
| Total Common Shares Outstanding | 64.81M | 58.92M | 54.03M | 45.92M | 39.44M | 36.90M |
| Working Capital | 305.44M | 247.82M | 192.70M | 184.52M | 212.68M | 212.08M |
| Book Value Per Share | 5.44 | 5.98 | 4.24 | 3.47 | 4.69 | 5.90 |
| Tangible Book Value | 352.59M | 352.46M | 229.02M | 159.56M | 184.85M | 217.78M |
| Tangible Book Value Per Share | 5.44 | 5.98 | 4.24 | 3.47 | 4.69 | 5.90 |
| Machinery | 10.46M | 10.31M | 10.13M | 8.57M | 4.93M | |
| Construction In Progress | 615.00K | 120.00K | 65.00K | 447.00K | 1.61M | |
| Leasehold Improvements | 2.21M | 2.33M | 2.29M | 1.87M | 263.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -6.88M | -88.98M | -104.70M | -101.07M | -85.81M | |
| Depreciation & Amortization | 1.77M | 2.18M | 2.47M | 1.55M | 974.00K | |
| Loss (Gain) From Sale of Assets | 145.00K | 1.00K | 29.00K | |||
| Asset Writedown & Restructuring Costs | 696.00K | |||||
| Loss (Gain) From Sale of Investments | -1.13M | -1.64M | -325.00K | -211.00K | 143.00K | |
| Stock-Based Compensation | 32.24M | 27.47M | 25.26M | 22.85M | 16.45M | |
| Other Operating Activities | 2.41M | 2.27M | 2.26M | 1.99M | 1.26M | |
| Change in Accounts Receivable | -4.27M | -50.00K | ||||
| Change in Accounts Payable | 21.29M | 3.09M | -3.21M | -3.53M | 2.90M | |
| Change in Unearned Revenue | -130.00K | -29.39M | -3.35M | 51.74M | ||
| Change in Other Net Operating Assets | -545.00K | -1.79M | 529.00K | -5.18M | -2.85M | |
| Operating Cash Flow | 45.59M | -86.85M | -81.07M | -31.87M | -66.91M | |
| Capital Expenditures | -670.00K | -203.00K | -1.62M | -3.96M | -1.20M | |
| Investment in Securities | -186.14M | -107.27M | 107.56M | -41.92M | -75.23M | |
| Investing Cash Flow | -186.81M | -107.47M | 105.95M | -45.88M | -76.43M | |
| Issuance of Common Stock | 97.39M | 131.09M | 53.01M | 46.41M | 1.29M | |
| Other Financing Activities | 1.00K | -2.00K | ||||
| Financing Cash Flow | 97.39M | 131.09M | 53.01M | 46.41M | 1.28M | |
| Net Cash Flow | -43.84M | -63.23M | 77.89M | -31.34M | -142.05M | |
| Free Cash Flow | 44.91M | -87.05M | -82.68M | -35.83M | -68.11M | |
| Free Cash Flow Margin | 24.36% | -238.15% | -941.72% | -288.82% | ||
| Free Cash Flow Per Share | 0.76 | -1.61 | -1.88 | -0.92 | -1.85 | |
| Levered Free Cash Flow | 33.02M | -26.46M | -45.10M | -36.15M | -34.78M | |
| Unlevered Free Cash Flow | 33.03M | -26.45M | -45.07M | -36.15M | -34.78M | |
| Change in Working Capital | 16.35M | -28.14M | -6.03M | 43.02M | 46.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.70B | 1.81B | 584.23M | 234.88M | 363.95M | 882.62M |
| Enterprise Value | 1.34B | 1.49B | 320.38M | 23.48M | 117.92M | 651.80M |
| Last Close Price | 26.29 | 31.74 | 11.03 | 5.26 | 9.23 | 23.99 |
| PS Ratio | 59.74 | 9.83 | 15.98 | 26.75 | 29.34 | |
| PB Ratio | 4.83 | 5.14 | 2.55 | 1.47 | 1.97 | 4.05 |
| P/TBV Ratio | 4.78 | 5.14 | 2.55 | 1.47 | 1.97 | 4.05 |
| P/FCF Ratio | 40.36 | |||||
| P/OCF Ratio | 39.77 | |||||
| EV/Sales Ratio | 47.04 | 8.07 | 8.76 | 2.67 | 9.51 | |
| EV/FCF Ratio | 33.15 | |||||
| Debt / Equity Ratio | 0.00 | 0.01 | 0.02 | 0.04 | 0.03 | 0.02 |
| Debt / FCF Ratio | 0.09 | |||||
| Net Debt / Equity Ratio | -1.02 | -1.10 | -1.06 | -1.22 | -1.22 | -0.99 |
| Net Debt / EBITDA Ratio | 1.40 | 20.55 | 2.44 | 1.73 | 2.18 | 2.52 |
| Net Debt / FCF Ratio | -8.61 | 2.78 | 2.35 | 6.27 | 3.15 | |
| Asset Turnover | 0.07 | 0.54 | 0.15 | 0.04 | 0.05 | |
| Quick Ratio | 6.72 | 5.05 | 5.47 | 6.54 | 7.33 | 12.83 |
| Current Ratio | 7.24 | 5.28 | 5.81 | 6.99 | 7.77 | 13.37 |
| Return on Equity (ROE) | -73.62% | -2.37% | -45.80% | -60.80% | -50.20% | -34.06% |
| Return on Assets (ROA) | -41.98% | -3.73% | -25.35% | -29.62% | -26.36% | -20.04% |
| Return on Capital Employed (ROCE) | -72.00% | -5.70% | -43.80% | -58.10% | -46.40% | -38.80% |
| Earnings Yield | -14.32% | -0.38% | -15.23% | -44.58% | -27.77% | -9.72% |
| FCF Yield | -10.72% | 2.48% | -14.90% | -35.20% | -9.84% | -7.72% |
| Buyback Yield / Dilution | -8.94% | -9.65% | -22.76% | -13.11% | -5.87% | -9.71% |